Cann Financial Statements From 2010 to 2025
| CNNA Stock | USD 0 0.0001 2.56% |
Check Cann American financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cann American's main balance sheet or income statement drivers, such as , as well as many indicators such as . Cann financial statements analysis is a perfect complement when working with Cann American Valuation or Volatility modules.
Cann |
Cann American Corp Company Current Valuation Analysis
Cann American's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Cann American Current Valuation | 48 |
Most of Cann American's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Cann American Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Cann American Corp has a Current Valuation of 48.0. This is 100.0% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The current valuation for all United States stocks is 100.0% higher than that of the company.
Cann American Corp Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Cann American's current stock value. Our valuation model uses many indicators to compare Cann American value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Cann American competition to find correlations between indicators driving Cann American's intrinsic value. More Info.Cann American Corp is rated second in return on equity category among its peers. It is number one stock in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Cann American by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Cann American's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.About Cann American Financial Statements
Cann American stakeholders use historical fundamental indicators, such as Cann American's revenue or net income, to determine how well the company is positioned to perform in the future. Although Cann American investors may analyze each financial statement separately, they are all interrelated. For example, changes in Cann American's assets and liabilities are reflected in the revenues and expenses on Cann American's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Cann American Corp. Please read more on our technical analysis and fundamental analysis pages.
Cann American Corp., a development stage company, focuses on the development of Cannabis sativa strains for pets in various European Union countries. Cann American Corp. was founded in 2004 and is based in Cloverdale, California. CANN AMERICAN operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 1 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Cann Pink Sheet
Cann American financial ratios help investors to determine whether Cann Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cann with respect to the benefits of owning Cann American security.